@MrTinvests@TheLongInvest What’s an ideal buy entry to start a position. I was thinking around $18 but it as a lot of strength recently. Not sure if we drop back to that level in the short term
For most men, health is about more than just losing weight, keeping your hair, or maintaining your sex life. It’s about trying to unlock a better version of yourself. The science is advancing and men’s options to feel great are expanding.
That’s why I’m so excited to welcome Dr. Anant Vinjamoori to the team as our Chief Medical Officer of @wearehims . He’s a leading expert in preventive and longevity care, and is one of the few clinicians in the world that has deep clinical experience and a command of the latest diagnostic and therapeutic technology (including peptides).
Joining Dr. Pat Carroll’s wider team of medical experts, Dr. Vinjamoori will provide the clinical guidance that shapes the next phase of the Hims brand across all of our categories – both existing and still to come.
Dr. Vinjamoori’s been at the leading edge of care for men for more than a decade, and I can’t wait for our Hims customers to feel his impact.
Welcome, Anant!
https://t.co/uM8EATZudH
There's no $hims bear thesis
Partnership with $nvo going smoothly
Eucalyptus acquisition closed, which makes $hims the largest D2C healthcare platform on Earth
Peptides coming
Longevity scape velocity coming
Revenue up a lot, stock price up little
Guess what happens next